Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches

R. Donken*, J. Hoes, M. J. Knol, G. S. Ogilvie, S. Dobson, A. J. King, J. Singer, P. J. Woestenberg, J. A. Bogaards, C. J. L. M. Meijer, H. E. de Melker

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number482
Number of pages11
JournalBMC Infectious Diseases
Volume20
Issue number1
DOIs
Publication statusPublished - 8 Jul 2020

Keywords

  • Human papillomavirus
  • HPV
  • Persistent infection
  • HPV vaccination
  • Follow-up
  • HPV-16/18 AS04-ADJUVANTED VACCINE
  • HUMAN-PAPILLOMAVIRUS TYPE-16
  • CROSS-PROTECTIVE EFFICACY
  • PATRICIA RANDOMIZED-TRIAL
  • SUSTAINED EFFICACY
  • DOUBLE-BLIND
  • PARTICLE VACCINE
  • YOUNG-WOMEN
  • FOLLOW-UP
  • CERVICAL COINFECTION

Cite this